Observational study on the effects of IL-6 inhibitor therapy on adipokines in patients with rheumatoid arthritis

Trial Profile

Observational study on the effects of IL-6 inhibitor therapy on adipokines in patients with rheumatoid arthritis

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Aug 2016

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 11 May 2016 Status changed from completed to active, no longer recruiting.
    • 02 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 23 Apr 2015 Planned End Date changed from 1 Sep 2015 to 1 Aug 2015 as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top